Global Signal Desk

Daily Signal Scan

Global Signal Scan — November 15, 2026

No qualifying changesScan edition Published Edited by Elijah St. John

Historical working ledger; no canonical active-record total was asserted for this edition.

Scan summary

An FDA obinutuzumab approval for primary membranous nephropathy, the Global Model WHO youth declaration on plastics and health, and PAHO’s regional dementia roadmap work. Selected reports date November 13, not November 15. No tracker record was changed.

Dated edition report

Prepared for 2026-11-15; first published November 17, 2026. The report below preserves historical evidence. See current signal records for later updates.

Global Signal Scan — November 15, 2026

Public Health Signals: Kidney Treatment, Plastics and Dementia

The November 15 scan explains a kidney-treatment approval, a youth plastics declaration and regional planning for dementia care. It is a targeted editorial scan, not comprehensive global surveillance. The selected reports are dated November 13; they are not new announcements made on November 15. The scan was prepared for November 15 and first published November 17, 2026. No tracker totals or risk levels were changed.

SignalSource clockFinding and treatment
Obinutuzumab approval for primary membranous nephropathyFDA, Nov 13FDA approved Gazyva (obinutuzumab) for adults with primary membranous nephropathy at risk of disease progression. The trial endpoint, time point and boxed warnings matter more than the word “remission.” Maya Bell analysis: [What “Complete Remission” Means in a New Kidney-Treatment Approval](/articles/gazyva-membranous-nephropathy-remission-endpoint).
Global Model WHO youth declaration on plastics and healthWHO, Nov 13Youth delegates adopted a declaration addressed to treaty negotiators and the 2027 World Health Assembly. It is a proposal, not evidence that governments have accepted its demands. Eli Ward analysis: [A Youth Plastics Declaration Is a Proposal to Negotiators](/articles/youth-plastics-health-declaration-treaty-process).
Regional dementia roadmapPAHO, Nov 13Representatives from seven countries advanced priorities for a 2027–2031 regional roadmap. It is planning work, not proof that a regional programme is operating. June Calder analysis: [A Dementia Diagnosis Needs Somewhere to Lead](/articles/americas-dementia-roadmap-care-beyond-diagnosis).

Coverage and uncertainty: Three selected signals are not the tracker total. Existing tracker records keep their original evidence cutoffs and are not labeled freshly verified by this scan; omission does not resolve any record.

How reported: AI-assisted review of the linked official sources, with analysis by TiPH editorial personas. Reviewed and approved for publication by Elijah St. John on November 17, 2026. No interviews or fieldwork. Consult signal methodology; material corrections identify what changed and when.

Social: A kidney approval, a youth plastics declaration and a dementia roadmap each need their label read carefully: an endpoint, a proposal and a plan.

Articles in this edition

Cite and share

Cite this edition

APA style
St. John, E. (2026, November 17). Global Signal Scan — November 15, 2026 (November 15, 2026 scan edition). Today in Public Health. https://www.todayinpublichealth.com/signals/daily/2026-11-15
Plain text
Today in Public Health. "Global Signal Scan — November 15, 2026." (November 15, 2026 scan edition). Edited by Elijah St. John. Published November 17, 2026. https://www.todayinpublichealth.com/signals/daily/2026-11-15

How this scan was run

Targeted editorial scan, not comprehensive global surveillance, prepared for November 15, 2026, first published November 17, 2026 and approved by Elijah St. John. The three selected signals are distinct from canonical tracker totals; no tracker totals or risk levels changed. Source reports are dated November 13, not November 15. Existing tracker records keep their original evidence cutoffs and are not labeled freshly verified.

Read the full desk methodology or repeat these checks yourself.

Sources cited in this edition

Linked desk records (with separate evidence dates)

This edition is situational awareness for public-health professionals and the public. It is not medical, clinical, or travel advice. Source-check limits and evidence cutoffs are stated on each current record; the desk adds a record only when a current source supports it, so an absence of new signals never implies an absence of global health risk.